This post is the argument your homepage should be making. Your whole thesis is that healthcare outreach is a precision problem, not a volume problem, and you land it cleanly: "Relevance drives response. Not list size."
Then your homepage opens with "14.67M+ verified contacts" and "at scale," which is the exact volume framing this entire post is dedicated to dismantling.
The essay sells precision, the landing page sells the database size you just told people to stop trusting, and the two undercut each other.
Move this post's thesis onto the page: lead with provider-level precision and specialty intelligence, who is in-market mapped to the real buying committee, and let the 14 million become proof that the precision runs deep rather than the headline. You clearly believe relevance beats list size. Make the homepage believe it too.
What made the page default to the volume number when your own writing argues the opposite?
This is a strong positioning angle because healthcare GTM really is not a normal contact-data problem. The difference between “more leads” and “the right provider ecosystem” is huge when specialties, affiliations, facility type, decision-makers, and clinical context all change the outreach motion.
The part I’d pressure-test is the brand frame. MedicalProspects is very clear, but it also sounds close to a descriptive list/database product. Your post is positioning something more valuable than that: healthcare audience intelligence, specialty segmentation, provider context, and precision GTM infrastructure.
If the product is meant to compete beyond a contact-list perception, the brand may need to feel more like an intelligence platform than a healthcare prospecting database.
Beryxa .com would fit that direction well because it gives the product a cleaner enterprise SaaS feel while still leaving room for healthcare data, provider intelligence, segmentation, GTM workflows, and decision systems under one brand.
About
Whether you're selling pharma, medical devices, software, or services - MedicalProspects puts you in front of the right physicians, nurses, hospital executives, and healthcare decision-makers. Verified contacts. Custom f
2 Comments
This post is the argument your homepage should be making. Your whole thesis is that healthcare outreach is a precision problem, not a volume problem, and you land it cleanly: "Relevance drives response. Not list size."
Then your homepage opens with "14.67M+ verified contacts" and "at scale," which is the exact volume framing this entire post is dedicated to dismantling.
The essay sells precision, the landing page sells the database size you just told people to stop trusting, and the two undercut each other.
Move this post's thesis onto the page: lead with provider-level precision and specialty intelligence, who is in-market mapped to the real buying committee, and let the 14 million become proof that the precision runs deep rather than the headline. You clearly believe relevance beats list size. Make the homepage believe it too.
What made the page default to the volume number when your own writing argues the opposite?
This is a strong positioning angle because healthcare GTM really is not a normal contact-data problem. The difference between “more leads” and “the right provider ecosystem” is huge when specialties, affiliations, facility type, decision-makers, and clinical context all change the outreach motion.
The part I’d pressure-test is the brand frame. MedicalProspects is very clear, but it also sounds close to a descriptive list/database product. Your post is positioning something more valuable than that: healthcare audience intelligence, specialty segmentation, provider context, and precision GTM infrastructure.
If the product is meant to compete beyond a contact-list perception, the brand may need to feel more like an intelligence platform than a healthcare prospecting database.
Beryxa .com would fit that direction well because it gives the product a cleaner enterprise SaaS feel while still leaving room for healthcare data, provider intelligence, segmentation, GTM workflows, and decision systems under one brand.